Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: Clinical, serological, and HLA class II gene associations

Galeazzi, Mauro;Annunziata, Pasquale;Sebastlani, Gian Domenico;Bellisai, Francesca;Marcolongo, Roberto;et.al.
(2000) Journal of Rheumatology — Vol. 27, n° 1, p. 135-141 (2000)

Files

No attached file found for this publication.

Details

Authors
  • Galeazzi, Mauro
    Author
  • Annunziata, Pasquale
    Author
  • Sebastlani, Gian Domenico
    Author
  • Bellisai, Francesca
    Author
  • Houssiau, FrédéricUCLouvain
    Author
  • Marcolongo, Roberto
    Author
Show more
Abstract
(en) OBJECTIVE: To assay anti-ganglioside antibodies (aGM1) in sera of a large cohort of European patients with systemic lupus erythematosus (SLE) to define the prevalence of these autoantibodies in SLE; to evaluate the association of aGM1 with clinical manifestations and other autoantibodies found in SLE; and to search for aGM1 association with HLA class II alleles. METHODS: Four hundred forty-eight patients with SLE were consecutively enrolled in 8 centers from 6 European countries. All sera were tested for antinuclear antibodies by immunofluorescence on HEp-2 cells as substrate, anti-dsDNA, aGM1, aCL, abeta2-glycoprotein I (abeta2-GPI) antibodies by ELISA, and antineutrophil cytoplasmic antibodies (ANCA) by immunofluorescence and by ELISA. Genomic typing for HLA class II loci was performed by polymerase chain reaction-sequence specific oligonucleotide probe method. Clinical assessment was done at the time of enrolment. RESULTS: We found 41.9% of patients with clinical signs of neuropsychiatric involvement; 15.5% of patients were positive for aGM1, 8% of the IgG isotype and 8.6% of the IgM isotype; aGM1-IgG were associated with neuropsychiatric manifestations (NPM) (RR = 3.7), with migraine (RR = 2.4), with OBS (RR = 7.3), and with peripheral neuropathy (RR = 8.5). aGM1-IgM were associated with NPM (RR = 4) and with depression (RR = 3.4). Furthermore, the genetic study showed that aGM1-IgG were associated with HLA-DQB1*0404 (RR = 7.2) while aGM1-IgM were associated with HLA-DQB1*0605 (RR = 33.3). No associations were found between aGM1 and anti-dsDNA, aCL, abeta2GP1, or ANCA. CONCLUSION: Our results show aGM1 can be found in patients with SLE. aGM1 may play a pathogenetic role for some NPM in this condition.
Affiliations

Citations

Galeazzi, M., Annunziata, P., Sebastlani, G. D., Bellisai, F., Campanella, V., Ferrara, G. B., Font, J., Houssiau, F., Passiu, G., De Ramon Garrido, E., Fernandez-Nebro, A., Bracci, L., Scorza, R., Puddu, P., Jedryka-Goral, A., Smolen, J., Tincani, A., Carcassi, C., Morozzi, G., & Marcolongo, R. (2000). Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: Clinical, serological, and HLA class II gene associations. Journal of Rheumatology, 27(1), 135-141. https://hdl.handle.net/2078.5/95529 (Original work published 2000)